MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)
Completed · Phase 2
Conditions studied: Hepatic Cirrhosis, Hepatic Encephalopathy (HE)
In brief
The main reason for this study is to see how the study drug interacts with the body. It will compare different doses of the study drug with a drug already in use. Participants will be adults with liver disease that has affected the brain in the past.
Key facts
- Study ID
- NCT03712280
- Run by
- Mallinckrodt
- People needed
- 50
- Starts
- 2018-12-01
- Expected to finish
- 2020-07-14
- Last updated by the study team
- 2021-07-20
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Southern California Research Center — Coronado, California, United States
- Inland Empire Clinical Trials — Rialto, California, United States
- Global Clinical Professionals — St. Petersburg, Florida, United States
- American Research Corporation at the Texas Liver Institute — San Antonio, Texas, United States
- Fundacion de Investigacion (Research Foundation) — San Juan, Puerto Rico
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.